(Q42793675)

7 November 2017

Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis (English)

1 reference

7 November 2017

Marla Lay

1 reference

7 November 2017

Rajan Mariappan

1 reference

7 November 2017

Jason Gotlib

1 reference

7 November 2017

Lisa Dietz

1 reference

7 November 2017

Siby Sebastian

1 reference

7 November 2017

Iris Schrijver

1 reference

7 November 2017

James L Zehnder

1 reference

7 November 2017

1 July 2006

1 reference

The Journal of Molecular Diagnostics

7 November 2017

1 reference

7 November 2017

1 reference

7 November 2017

1 reference

7 November 2017

330-334

1 reference

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

A gain-of-function mutation of JAK2 in myeloproliferative disorders

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867612

JAK2 mutations in myeloproliferative disorders

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16825505

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16825505

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2353/JMOLDX.2006.050130

1 reference

7 November 2017

1 reference

7 November 2017

PubMed publication ID

16825505

1 reference